Recent News

• 03.10.2025 - Corcept Therapeutics Initiates MOMENTUM Trial to Determine Prevalence of Hypercortisolism in Patients with Resistant Hypertension
• 03.10.2025 - Corcept Therapeutics Initiates MOMENTUM Trial to Determine Prevalence of Hypercortisolism in Patients with Resistant Hypertension
• 03.03.2025 - FDA Files Corcept’s New Drug Application for Relacorilant as Treatment for Patients With Hypercortisolism
• 03.03.2025 - FDA Files Corcept’s New Drug Application for Relacorilant as Treatment for Patients With Hypercortisolism
• 02.26.2025 - Corcept Therapeutics Q4 2024 Earnings Conference Call
• 02.26.2025 - Corcept Therapeutics Q4 2024 Earnings Conference Call

Recent Filings

• 03.10.2025 - 144 Report of proposed sale of securities
• 03.04.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.04.2025 - 144 Report of proposed sale of securities
• 03.04.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.04.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.04.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.04.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.04.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.04.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.03.2025 - 8-K Current report